Summary

KEY FINDINGS
The Asia-Pacific ECG equipment market size is valued at $2,212.14 million as of 2026 and is expected to reach $4,171.67 million by 2034, progressing with a CAGR of 8.25% during the forecast years, 2026-2034.
MARKET INSIGHTS
The Asia-Pacific region emerges as the fastest-growing ECG equipment market globally, propelled by massive population demographics, rapidly expanding healthcare infrastructure, and increasing cardiovascular disease burden across diverse economies. Rising prosperity throughout emerging Asian economies enables greater healthcare investment and improved access to advanced cardiac diagnostic equipment.
Furthermore, government initiatives across multiple nations prioritize non-communicable disease prevention, with cardiovascular conditions receiving particular emphasis in national health strategies. Urbanization trends across the region contribute to lifestyle changes that elevate heart disease risk factors, subsequently driving demand for diagnostic technologies. Additionally, medical tourism growth in countries like Thailand, India, and Singapore encourages hospitals to invest in state-of-the-art ECG monitoring systems that meet international quality standards.
The region's aging demographics, particularly pronounced in Japan, South Korea, and China, create a sustained need for cardiovascular care services and equipment. Moreover, technology adoption accelerates as healthcare providers increasingly embrace digital ECG systems, AI-assisted ECG interpretation systems, and telemedicine platforms extending cardiac care to remote populations. International medical device manufacturers recognize the region's growth potential, establishing local manufacturing facilities and distribution networks to capture market opportunities.
REGIONAL ANALYSIS
The Asia-Pacific ECG equipment market growth assessment includes the analysis of China, Japan, India, South Korea, Indonesia, Vietnam, Thailand, Australia & New Zealand, and Rest of Asia-Pacific.
China dominates the Asia-Pacific ECG equipment market through its enormous population, aggressive healthcare modernization programs, and substantial government health expenditure supporting universal coverage initiatives. The country continues experiencing rapid cardiovascular disease prevalence growth, with heart conditions affecting millions of citizens across urban and rural areas. China's ambitious Healthy China 2030 initiative drives massive healthcare infrastructure investment, including extensive hospital construction and primary care facility upgrades requiring comprehensive diagnostic equipment.
Consequently, demand surges for hospital ECG equipment, clinic-based ECG systems, and portable ECG monitors deployed across the tiered healthcare delivery network. Furthermore, China's domestic medical device industry has matured significantly, with companies like Mindray Medical International Limited producing cost-competitive equipment meeting both domestic needs and export demands. The government's hierarchical medical system reform encourages patient treatment at community health centers, accelerating the adoption of point-of-care ECG devices in primary care settings.
Additionally, China's vast rural population creates substantial opportunities for telecardiology solutions connecting remote clinics with urban specialist centers through digital ECG systems and cloud-enabled platforms. The National Medical Products Administration streamlines approval processes for innovative cardiac monitoring technologies while maintaining safety standards. Moreover, China's growing middle class increasingly seeks preventive healthcare services, driving routine cardiac screening adoption using ambulatory ECG systems and wearable ECG devices.
Public health insurance expansion ensures broader population access to ECG diagnostic services across socioeconomic groups. Urban hospitals invest heavily in advanced ECG monitoring systems featuring AI-assisted interpretation capabilities and multi-channel recording functionality for sophisticated cardiac assessments.
Japan's ECG equipment market reflects the country's status as a super-aging society with world-leading longevity and sophisticated healthcare delivery systems. According to government health data, Japan maintains remarkably low cardiovascular mortality rates despite population aging, with heart failure prevalence projected to reach 1.3 million by 2030. The country implemented the Japanese National Plan for Promotion of Measures Against Cerebrovascular and Cardiovascular Disease, coordinating prefecture-level health initiatives nationwide.
Japan's universal health insurance system ensures comprehensive coverage for cardiac diagnostic services, supporting widespread ECG equipment deployment across all healthcare facilities. Moreover, the country's cultural emphasis on preventive medicine drives high participation rates in routine health examinations incorporating ECG screening. Japanese hospitals maintain extremely high technical standards, favoring premium-quality ECG systems from established manufacturers with proven reliability records.
Furthermore, Japan's medical device regulatory environment, overseen by the Pharmaceuticals and Medical Devices Agency, enforces rigorous safety and efficacy requirements matching international benchmarks. The country's compact geography and excellent transportation infrastructure enable centralized maintenance and support services for sophisticated cardiology diagnostic equipment. Additionally, Japan's technological sophistication extends to cardiac care, with widespread adoption of digital ECG systems, computerized analysis platforms, and integrated hospital information systems.
In all, the aging population particularly requires heart failure monitoring and chronic cardiac condition management, driving demand for ambulatory ECG systems and remote monitoring solutions. Japanese medical device manufacturers, including Nihon Kohden Corporation, contribute significant innovation in cardiac monitoring technology while maintaining strong domestic market positions.
SEGMENTATION ANALYSIS
The Asia-Pacific ECG equipment market is segmented into product type, technology, number of leads, portability, application, and end use industry. The application segment is further categorized into cardiovascular disease diagnosis, arrhythmia detection, and other applications.
Cardiovascular disease diagnosis represents a large application segment within the Asia-Pacific ECG equipment market, reflecting the primary clinical purpose of electrocardiography in detecting and assessing heart conditions. ECG technology serves as the foundational diagnostic tool for identifying various cardiac abnormalities, including coronary artery disease, myocardial infarction, cardiomyopathy, and structural heart defects.
Healthcare providers across the region rely on ECG examinations as the initial diagnostic step when patients present with chest pain, shortness of breath, palpitations, or other cardiac symptoms. Moreover, the non-invasive nature of ECG testing makes it particularly suitable for widespread deployment across diverse healthcare settings throughout developing and developed Asian markets. The application encompasses both symptomatic patient evaluation and asymptomatic screening programs, identifying previously undetected cardiovascular conditions.
Consequently, hospitals utilize ECG equipment extensively in emergency departments for rapid cardiac assessment of acute cases requiring immediate intervention decisions. Cardiology departments employ sophisticated ECG systems for comprehensive diagnostic workups preceding interventional procedures or surgical interventions. Furthermore, the rising cardiovascular disease burden throughout Asia-Pacific nations amplifies the clinical need for accurate, timely cardiac diagnostics supporting treatment planning and patient management.
Public health initiatives promoting early disease detection drive increased ECG screening adoption across at-risk populations, particularly elderly demographics and individuals with diabetes, hypertension, or family cardiac history. Additionally, insurance reimbursement policies throughout the region typically cover ECG diagnostic procedures, removing financial barriers for patients seeking cardiac evaluations. The application benefits from continuous technological advancement, improving diagnostic accuracy and expanding detection capabilities for subtle cardiac abnormalities that older equipment might miss.
COMPETITIVE INSIGHTS
Some of the top players operating in the Asia-Pacific ECG equipment market include GE Healthcare, Philips Healthcare, Nihon Kohden Corporation, Mindray Medical International Limited, etc.
Nihon Kohden Corporation stands as a prominent Japanese medical electronics company with a substantial presence throughout the Asia-Pacific ECG equipment market. The corporation specializes in manufacturing physiological measuring equipment, patient monitoring systems, and treatment devices serving hospitals, clinics, and emergency medical services globally. Headquartered in Tokyo, Nihon Kohden maintains research facilities, manufacturing plants, and sales operations across Japan and international markets.
The company's ECG product portfolio encompasses resting electrocardiographs, stress testing systems, Holter recorders, and central monitoring stations designed for various clinical environments. Their Cardiofax series represents a flagship ECG platform combining advanced diagnostic capabilities with user-friendly operation suitable for both hospital and clinic applications. These systems integrate sophisticated interpretation algorithms supporting clinicians in identifying cardiac abnormalities and generating comprehensive diagnostic reports.
Furthermore, Nihon Kohden's equipment features Japanese-language interfaces and clinical workflows tailored to domestic healthcare practices while offering multilingual capabilities for export markets. The company leverages decades of experience in physiological monitoring, incorporating deep clinical expertise into product development processes. Additionally, Nihon Kohden maintains extensive service networks throughout Asia-Pacific countries, providing installation support, user training, preventive maintenance, and rapid technical assistance, ensuring optimal equipment performance.
COMPANY PROFILES
1. BIONET CO LTD
2. BIOTELEMETRY INC
3. GE HEALTHCARE
4. MCKESSON CORPORATION
5. MINDRAY MEDICAL INTERNATIONAL LIMITED
6. NIHON KOHDEN CORPORATION
7. PHILIPS HEALTHCARE
8. SCHILLER AG
9. SPACELABS HEALTHCARE
10. ZOLL MEDICAL CORPORATION
11. BAXTER

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & FORECAST
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. HOSPITALS REMAIN THE LARGEST END-USERS DUE TO HIGH PROCEDURE VOLUMES AND CRITICAL CARE REQUIREMENTS
2.5.2. PORTABLE AND HANDHELD ECG DEVICES ARE GAINING STRONG ADOPTION IN OUTPATIENT AND HOME CARE SETTINGS
2.5.3. RESTING ECG SYSTEMS CONTINUE TO DOMINATE REVENUE SHARE WHILE AMBULATORY MONITORING SHOWS FASTER GROWTH
2.5.4. EMERGING MARKETS ARE EXPERIENCING RAPID DEMAND GROWTH DRIVEN BY HEALTHCARE INFRASTRUCTURE EXPANSION
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CARDIOVASCULAR DISEASES IS INCREASING DIAGNOSTIC ECG DEMAND GLOBALLY
3.1.2. AGING POPULATIONS ARE DRIVING HIGHER INCIDENCE OF ARRHYTHMIAS AND CHRONIC HEART CONDITIONS
3.1.3. TECHNOLOGICAL ADVANCEMENTS, SUCH AS WIRELESS AND AI-ENABLED ECG SYSTEMS, ARE EXPANDING CLINICAL USE CASES
3.1.4. GROWING FOCUS ON PREVENTIVE HEALTHCARE IS BOOSTING SCREENING AND ROUTINE CARDIAC MONITORING
3.2. KEY RESTRAINTS
3.2.1. HIGH INITIAL COST OF ADVANCED ECG SYSTEMS LIMITS ADOPTION IN SMALL CLINICS AND RURAL SETTINGS
3.2.2. LACK OF SKILLED HEALTHCARE PROFESSIONALS AFFECTS ACCURATE ECG INTERPRETATION IN DEVELOPING REGIONS
3.2.3. STRINGENT REGULATORY APPROVAL PROCESSES CAN DELAY PRODUCT LAUNCHES AND MARKET ENTRY
3.2.4. DATA PRIVACY AND CYBERSECURITY CONCERNS POSE CHALLENGES FOR CONNECTED AND CLOUD BASED ECG DEVICES
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. SHIFT TOWARD PORTABLE AND WEARABLE ECG DEVICES IS TRANSFORMING CARDIAC MONITORING PRACTICES
4.1.2. INTEGRATION OF ARTIFICIAL INTELLIGENCE IS IMPROVING ARRHYTHMIA DETECTION AND DIAGNOSTIC ACCURACY
4.1.3. INCREASING USE OF TELECARDIOLOGY IS EXPANDING ECG ACCESS IN REMOTE AND UNDERSERVED AREAS
4.1.4. MULTIPARAMETER MONITORING SYSTEMS ARE COMBINING ECG WITH OTHER VITAL SIGNS FOR HOLISTIC CARE
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
4.6.1. RAW MATERIAL SUPPLIERS
4.6.2. ELECTRONIC COMPONENTS
4.6.3. DEVICE MANUFACTURING
4.6.4. SOFTWARE INTEGRATION
4.6.5. QUALITY TESTING
4.6.6. DISTRIBUTION CHANNELS
4.6.7. END-USER DELIVERY
4.7. KEY BUYING CRITERIA
4.7.1. DIAGNOSTIC ACCURACY
4.7.2. DEVICE PORTABILITY
4.7.3. REGULATORY APPROVAL
4.7.4. TOTAL COST OWNERSHIP
4.8. REGULATORY FRAMEWORK
5. ECG EQUIPMENT MARKET BY PRODUCT TYPE
5.1. RESTING ECG DEVICES
5.1.1. MARKET FORECAST FIGURE
5.1.2. SEGMENT ANALYSIS
5.2. STRESS ECG DEVICES
5.2.1. MARKET FORECAST FIGURE
5.2.2. SEGMENT ANALYSIS
5.3. HOLTER MONITORS
5.3.1. MARKET FORECAST FIGURE
5.3.2. SEGMENT ANALYSIS
5.4. ADVANCED ECG DEVICES
5.4.1. MARKET FORECAST FIGURE
5.4.2. SEGMENT ANALYSIS
5.5. OTHER PRODUCT TYPES
5.5.1. MARKET FORECAST FIGURE
5.5.2. SEGMENT ANALYSIS
6. ECG EQUIPMENT MARKET BY TECHNOLOGY
6.1. ANALOG
6.1.1. MARKET FORECAST FIGURE
6.1.2. SEGMENT ANALYSIS
6.2. DIGITAL
6.2.1. MARKET FORECAST FIGURE
6.2.2. SEGMENT ANALYSIS
7. ECG EQUIPMENT MARKET BY NUMBER OF LEADS
7.1. 1 CHANNEL
7.1.1. MARKET FORECAST FIGURE
7.1.2. SEGMENT ANALYSIS
7.2. 3 CHANNELS
7.2.1. MARKET FORECAST FIGURE
7.2.2. SEGMENT ANALYSIS
7.3. 6 CHANNELS
7.3.1. MARKET FORECAST FIGURE
7.3.2. SEGMENT ANALYSIS
7.4. 12 CHANNELS
7.4.1. MARKET FORECAST FIGURE
7.4.2. SEGMENT ANALYSIS
8. ECG EQUIPMENT MARKET BY PORTABILITY
8.1. STATIONARY
8.1.1. MARKET FORECAST FIGURE
8.1.2. SEGMENT ANALYSIS
8.2. PORTABLE
8.2.1. MARKET FORECAST FIGURE
8.2.2. SEGMENT ANALYSIS
9. ECG EQUIPMENT MARKET BY APPLICATION
9.1. CARDIOVASCULAR DISEASE DIAGNOSIS
9.1.1. MARKET FORECAST FIGURE
9.1.2. SEGMENT ANALYSIS
9.2. ARRHYTHMIA DETECTION
9.2.1. MARKET FORECAST FIGURE
9.2.2. SEGMENT ANALYSIS
9.3. OTHER APPLICATIONS
9.3.1. MARKET FORECAST FIGURE
9.3.2. SEGMENT ANALYSIS
10. ECG EQUIPMENT MARKET BY END USE INDUSTRY
10.1. HOSPITALS
10.1.1. MARKET FORECAST FIGURE
10.1.2. SEGMENT ANALYSIS
10.2. SPECIALTY CLINICS
10.2.1. MARKET FORECAST FIGURE
10.2.2. SEGMENT ANALYSIS
10.3. AMBULATORY SURGICAL CENTRES
10.3.1. MARKET FORECAST FIGURE
10.3.2. SEGMENT ANALYSIS
10.4. OTHER END USE INDUSTRIES
10.4.1. MARKET FORECAST FIGURE
10.4.2. SEGMENT ANALYSIS
11. GEOGRAPHICAL ANALYSIS
11.1. ASIA-PACIFIC
11.1.1. MARKET SIZE & ESTIMATES
11.1.2. ASIA-PACIFIC MARKET DRIVERS
11.1.3. ASIA-PACIFIC MARKET CHALLENGES
11.1.4. KEY PLAYERS IN ASIA-PACIFIC ECG EQUIPMENT MARKET
11.1.5. COUNTRY ANALYSIS
11.1.5.1. CHINA
11.1.5.1.1. CHINA MARKET SIZE & OPPORTUNITIES
11.1.5.2. INDIA
11.1.5.2.1. INDIA MARKET SIZE & OPPORTUNITIES
11.1.5.3. JAPAN
11.1.5.3.1. JAPAN MARKET SIZE & OPPORTUNITIES
11.1.5.4. AUSTRALIA & NEW ZEALAND
11.1.5.4.1. AUSTRALIA & NEW ZEALAND MARKET SIZE & OPPORTUNITIES
11.1.5.5. SOUTH KOREA
11.1.5.5.1. SOUTH KOREA MARKET SIZE & OPPORTUNITIES
11.1.5.6. THAILAND
11.1.5.6.1. THAILAND MARKET SIZE & OPPORTUNITIES
11.1.5.7. INDONESIA
11.1.5.7.1. INDONESIA MARKET SIZE & OPPORTUNITIES
11.1.5.8. VIETNAM
11.1.5.8.1. VIETNAM MARKET SIZE & OPPORTUNITIES
11.1.5.9. REST OF ASIA-PACIFIC
11.1.5.9.1. REST OF ASIA-PACIFIC MARKET SIZE & OPPORTUNITIES
12. COMPETITIVE LANDSCAPE
12.1. KEY STRATEGIC DEVELOPMENTS
12.1.1. MERGERS & ACQUISITIONS
12.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
12.1.3. PARTNERSHIPS & AGREEMENTS
12.1.4. BUSINESS EXPANSIONS & DIVESTITURES
12.2. COMPANY PROFILES
12.2.1. BIONET CO LTD
12.2.1.1. COMPANY OVERVIEW
12.2.1.2. PRODUCT LIST
12.2.1.3. STRENGTHS & CHALLENGES
12.2.2. BIOTELEMETRY INC
12.2.2.1. COMPANY OVERVIEW
12.2.2.2. PRODUCT LIST
12.2.2.3. STRENGTHS & CHALLENGES
12.2.3. GE HEALTHCARE
12.2.3.1. COMPANY OVERVIEW
12.2.3.2. PRODUCT LIST
12.2.3.3. STRENGTHS & CHALLENGES
12.2.4. MCKESSON CORPORATION
12.2.4.1. COMPANY OVERVIEW
12.2.4.2. PRODUCT LIST
12.2.4.3. STRENGTHS & CHALLENGES
12.2.5. MINDRAY MEDICAL INTERNATIONAL LIMITED
12.2.5.1. COMPANY OVERVIEW
12.2.5.2. PRODUCT LIST
12.2.5.3. STRENGTHS & CHALLENGES
12.2.6. NIHON KOHDEN CORPORATION
12.2.6.1. COMPANY OVERVIEW
12.2.6.2. PRODUCT LIST
12.2.6.3. STRENGTHS & CHALLENGES
12.2.7. PHILIPS HEALTHCARE
12.2.7.1. COMPANY OVERVIEW
12.2.7.2. PRODUCT LIST
12.2.7.3. STRENGTHS & CHALLENGES
12.2.8. SCHILLER AG
12.2.8.1. COMPANY OVERVIEW
12.2.8.2. PRODUCT LIST
12.2.8.3. STRENGTHS & CHALLENGES
12.2.9. SPACELABS HEALTHCARE (SUBSIDIARY OF OSI SYSTEMS INC)
12.2.9.1. COMPANY OVERVIEW
12.2.9.2. PRODUCT LIST
12.2.9.3. STRENGTHS & CHALLENGES
12.2.10. ZOLL MEDICAL CORPORATION (ACQUIRED BY ASAHI KASEI)
12.2.10.1. COMPANY OVERVIEW
12.2.10.2. PRODUCT LIST
12.2.10.3. STRENGTHS & CHALLENGES
12.2.11. BAXTER
12.2.11.1. COMPANY OVERVIEW
12.2.11.2. PRODUCT LIST
12.2.11.3. STRENGTHS & CHALLENGES



LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - ECG EQUIPMENT
TABLE 2: ECG EQUIPMENT MARKET REGULATORY FRAMEWORK
TABLE 3: MARKET BY PRODUCT TYPE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 4: MARKET BY PRODUCT TYPE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 5: MARKET BY TECHNOLOGY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 6: MARKET BY TECHNOLOGY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 7: MARKET BY NUMBER OF LEADS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 8: MARKET BY NUMBER OF LEADS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 9: MARKET BY PORTABILITY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 10: MARKET BY PORTABILITY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 12: MARKET BY APPLICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 13: MARKET BY END USE INDUSTRY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 14: MARKET BY END USE INDUSTRY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC MARKET, COUNTRY ANALYSIS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC MARKET, COUNTRY ANALYSIS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 17: KEY PLAYERS OPERATING IN THE ASIA-PACIFIC MARKET
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR ASIA-PACIFIC
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: SEGMENT GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2025
FIGURE 9: RESTING ECG DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 10: STRESS ECG DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 11: HOLTER MONITORS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 12: ADVANCED ECG DEVICES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 13: OTHER PRODUCT TYPES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 14: SEGMENT GROWTH POTENTIAL, BY TECHNOLOGY, IN 2025
FIGURE 15: ANALOG MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 16: DIGITAL MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 17: SEGMENT GROWTH POTENTIAL, BY NUMBER OF LEADS, IN 2025
FIGURE 18: 1 CHANNEL MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 19: 3 CHANNELS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 20: 6 CHANNELS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 21: 12 CHANNELS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 22: SEGMENT GROWTH POTENTIAL, BY PORTABILITY, IN 2025
FIGURE 23: STATIONARY MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 24: PORTABLE MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 25: SEGMENT GROWTH POTENTIAL, BY APPLICATION, IN 2025
FIGURE 26: CARDIOVASCULAR DISEASE DIAGNOSIS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 27: ARRHYTHMIA DETECTION MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 28: OTHER APPLICATIONS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 29: SEGMENT GROWTH POTENTIAL, BY END USE INDUSTRY, IN 2025
FIGURE 30: HOSPITALS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 31: SPECIALTY CLINICS MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 32: AMBULATORY SURGICAL CENTRES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 33: OTHER END USE INDUSTRIES MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 34: ASIA-PACIFIC ECG EQUIPMENT MARKET, COUNTRY OUTLOOK, 2025 & 2034 (IN %)
FIGURE 35: CHINA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 36: INDIA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 37: JAPAN MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 38: AUSTRALIA & NEW ZEALAND MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 39: SOUTH KOREA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 40: THAILAND MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 41: INDONESIA MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 42: VIETNAM MARKET SIZE, 2026-2034 (IN $ MILLION)
FIGURE 43: REST OF ASIA-PACIFIC MARKET SIZE, 2026-2034 (IN $ MILLION)

ページTOPに戻る

List of Tables/Graphs

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - ECG EQUIPMENT
TABLE 2: ECG EQUIPMENT MARKET REGULATORY FRAMEWORK
TABLE 3: MARKET BY PRODUCT TYPE, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 4: MARKET BY PRODUCT TYPE, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 5: MARKET BY TECHNOLOGY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 6: MARKET BY TECHNOLOGY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 7: MARKET BY NUMBER OF LEADS, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 8: MARKET BY NUMBER OF LEADS, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 9: MARKET BY PORTABILITY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 10: MARKET BY PORTABILITY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 11: MARKET BY APPLICATION, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 12: MARKET BY APPLICATION, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 13: MARKET BY END USE INDUSTRY, BY REGION, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 14: MARKET BY END USE INDUSTRY, BY REGION, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 15: ASIA-PACIFIC MARKET, COUNTRY ANALYSIS, HISTORICAL YEARS, 2022-2024 (IN $ MILLION)
TABLE 16: ASIA-PACIFIC MARKET, COUNTRY ANALYSIS, FORECAST YEARS, 2026-2034 (IN $ MILLION)
TABLE 17: KEY PLAYERS OPERATING IN THE ASIA-PACIFIC MARKET
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES